The research team has developed a new class of non-viral gene-delivery systems, inside which genetic material (DNA or RNA) can be packaged. Through further specific signaling molecules, it is also possible to specify the precise destination of the delivery system, such as certain cells. Initial tests of this gene-therapy approach in an animal model have been successful: By inhalation of the delivery system, the researchers managed to introduce a healthy copy of the CFTR gene into the genome of lung cells. The authors of the study were then also able to prove that the introduced gene actually produced the CFTR protein as well as the chloride channel.

According to the authors of the study, this new technology may also be used for other rare lung diseases. First of all, however, further comprehensive studies are necessary to evaluate various factors, such as the safety of the method. Because if the gene is introduced incorrectly into the genome, this may have serious consequences. Moreover, it is not yet clear whether the method can be extrapolated to humans.

Original publication:
Shan Guan et al.: Self-assembled peptide – poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis. In: Nature Nanotechnology 2019; doi: 10.1038/s41565-018-0358-x

Source: Lung Information Service

Upcoming Events

19.06.2019 - 21.06.2019
Bronchitis X
23.08.2019 - 24.08.2019
Summer School Pädiatrische Pneumologie 2019
07.09.2019 - 07.09.2019
12. Symposium Lunge
11.09.2019 - 13.09.2019
ETRS Annual Meeting 2019